Isabel Maria Socias Buades

Zamanillo-Campos R, Fiol-deRoque MA, Serrano-Ripoll MJ, Llobera-Canaves J, Taltavull-Aparicio JM, Leiva-Rus A, Ripoll-Amengual J, Angullo-Martínez E, Socias-Buades IM, Masmiquel-Comas L, Konieczna J, Zaforteza-Dezcallar M, Boronat-Moreiro MA, Mira-Martínez S, Gervilla-García E, Ricci-Cabello I. Impact of an SMS intervention to support type 2 diabetes self-management: DiabeText clinical trial. Br J Gen Pract. 2025 Jun 26;75(756):e457-e465. doi: 10.3399/BJGP.2024.0206. PMID: 39362693; PMCID: PMC11755587.

Bennasar-Veny M, Abbate M, Colom-Rosselló M, Capitán-Moyano L, Hernández-Bermúdez IC, Ricci-Cabello I, Yañez AM, Fernandez ME; ALADIM investigators. Impact of an adapted diabetes prevention program in a spanish primary care setting: protocol for a type II hybrid effectiveness-implementation cluster-randomized trial (ALADIM). Implement Sci. 2025 Jun 2;20(1):27. doi: 10.1186/s13012-025-01438-3. PMID: 40457444; PMCID: PMC12131578.

Vicens C, Leiva A, Bejarano F, Sempere-Verdú E, Rodríguez-Rincón RM, Fiol F, Mengual M, Ajenjo-Navarro A, Do Pazo F, Mateu C, Folch S, Alegret S, Coll JM, Martín-Rabadán M, Socias I. Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners: The BENZORED hybrid type 1 cluster randomized controlled trial. PLoS Med. 2022 May 6;19(5):e1003983. doi: 10.1371/journal.pmed.1003983. PMID: 35522626; PMCID: PMC9075619.

Vicens C, Leiva A, Bejarano F, Sempere E, Rodríguez-Rincón RM, Fiol F, Mengual M, Ajenjo A, Do Pazo F, Mateu C, Folch S, Alegret S, Coll JM, Martín-Rabadán M, Socias I. Intervention to reduce benzodiazepine prescriptions in primary care, study protocol of a hybrid type 1 cluster randomised controlled trial: the BENZORED study. BMJ Open. 2019 Jan 30;9(1):e022046. doi: 10.1136/bmjopen-2018-022046. PMID: 30705235; PMCID: PMC6359733.